Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

99.18
Delayed Data
As of Feb 08
 +1.29 / +1.32%
Today’s Change
92.98
Today|||52-Week Range
140.72
-17.18%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Celgene have a median target of 144.00, with a high estimate of 163.00 and a low estimate of 90.00. The median estimate represents a +45.19% increase from the last price of 99.18.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Celgene. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.27
Sales
$2.6B
Reporting Date
Apr 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.89%
 
 
 
 
 
 
Growthannually 20.45%
 
 
 
 
 
 

Sales

Growthquarterly 1.00%
 
 
 
 
 
 
Growthannually 20.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.